|treatment for dementia ncbi||1.44||0.7||8335||100|
Rivastigmine and Galantamine has been approved for mild to moderate Alzheimer's dementia Memantine has been approved for moderate to severe Alzheimer's dementia Combination of Donepezil and Memantine has been approved for moderate to Severe Alzheimer's dementiaWhat are non-pharmacological interventions for mild to moderate dementia?
PSYCHOSOCIAL INTERVENTIONS Open in a separate window Non-pharmacological interventions for cognitive symptoms People with mild to moderate dementia of all types should be encouraged to participate in structured cognitive stimulation programmes. They benefit cognition in such patients irrespective of whether any drug is prescribed or not.Which medications are used to treat Alzheimer disease?
For Alzheimer disease, this includes an acetylcholinesterase inhibitor such as donepezil for mild to severe dementia, and memantine (used alone or as an add-on therapy) for moderate to severe dementia. Rivastigmine can be used to treat symptomatic Parkinson disease dementia.Are acetyl-cholinesterase inhibitors effective for dementia?
Responses to a survey conducted by the Alzheimer’s Society indicate that many people with dementia and many carers experience beneficial effects from drug treatment for dementia using acetyl-cholinesterase inhibitors or memantine.